← Back to Search

Educational Video for Cancer Understanding

N/A

Recruiting

Led By Daniel G Stover, MD

Research Sponsored by Ohio State University Comprehensive Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be >= 18 years of age

Be undergoing clinical tumor or circulating tumor deoxyribonucleic acid (DNA) NGS

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediately before and immediately after video intervention

Awards & highlights

Study Summary

This trial is testing whether a video can help patients understand genomic testing for metastatic cancer. Results may help doctors provide better patient care by communicating the importance of this type of testing.

Who is the study for?

This trial is for adults over 18 with metastatic cancer who are undergoing tumor DNA sequencing. It's designed to see if a video can help them understand their genomic testing better. Participants must speak English or Spanish, and have confirmed biopsy results.Check my eligibility

What is being tested?

The study is evaluating the effectiveness of an educational video intervention on patients' comprehension of tumor genomic testing. The goal is to determine if this approach can enhance patient-centered care by improving communication about genomic tests.See study design

What are the potential side effects?

Since the interventions include health education and questionnaire administration, there are no direct medical side effects associated with typical drugs or treatments; however, participants may experience stress or anxiety related to learning about their condition.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am currently having genetic testing on my cancer.

Select...

My cancer has spread, confirmed by a biopsy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ immediately before and immediately after video intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~immediately before and immediately after video intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately before and immediately after video intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Message-specific knowledge/recall accuracy

Secondary outcome measures

Change in patient genomic knowledge

Change in patient genomic knowledge in metastatic breast cancer (MBC) versus metastatic lung cancer (MLC) patients

Change in patient trust of physician/provider

+1 more

Side effects data

From 2020 Phase 3 trial • 177 Patients • NCT01817075

13%

Rash maculo-papular

10%

Skin and subcutaneous tissue disorders - Other, specify

Mucositis oral

Sepsis

Skin ulceration

Urticaria

100%

80%

60%

40%

20%

Study treatment Arm

Arm I (CHG Cleansing Wipe)

Arm II (Control)

Trial Design

1Treatment groups

Experimental Treatment

Group I: Health services research (video)Experimental Treatment2 Interventions

Patients participate in a video intervention session and complete questionnaires at baseline, after participating in the video intervention, and after receiving NGS results.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Health Education

2014

Completed Phase 3

~4010

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,663 Previous Clinical Trials

40,925,680 Total Patients Enrolled

Ohio State University Comprehensive Cancer CenterLead Sponsor

320 Previous Clinical Trials

289,942 Total Patients Enrolled

Daniel G Stover, MDPrincipal InvestigatorOhio State University Comprehensive Cancer Center

Media Library

Health Education Clinical Trial Eligibility Overview. Trial Name: NCT05215769 — N/A

Cancer Research Study Groups: Health services research (video)

Cancer Clinical Trial 2023: Health Education Highlights & Side Effects. Trial Name: NCT05215769 — N/A

Health Education 2023 Treatment Timeline for Medical Study. Trial Name: NCT05215769 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the total cohort size of this clinical trial?

"Affirmative, the information held on clinicaltrials.gov confirms that this trial is still seeking participants as of April 18th 2022. Initially posted on April 6th, it requires 225 individuals to be enrolled from a single site."

Answered by AI

Are there any available appointments for this medical experiment?

"Affirmative. Clinicaltrials.gov indicates that this trial, which was first published on April 6th 2022 and is actively enrolling participants, needs 225 people to join from 1 medical site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer

Daniel Stover 2022. "A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05215769.